Skyline Medical, Inc. (SKLN) Partners with GLG Pharma to Develop Oncology Test Panels
Skyline Medical (NASDAQ: SKLN), producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal, has entered into an exclusive reseller agreement in which GLG Pharma, LLC intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures. Per the agreement, Skyline will issue common stock to GLG Pharma in four separate tranches, with each tranche released after the achievement of certain development milestones. In addition, Skyline will pay a royalty to GLG on the sale of individual tests. To view the full press release, visit: http://nnw.fm/CgH4x About Skyline Medical, Inc. Skyline…







